Innovation with the alfapump® system at Inselspital Bern

21 July 2013

The latest edition of Inselspital's “Ärztemagazin” reports on their adoption of the alfapump system for patients with cirrhotic ascites.  The project has been funded from the hospital ‘Innovationsfond’. 

Read more

Sequana Medical selected to present at this year's Healthtech Summit in London

25 June 2013

This year’s Healthtech Summit took place on 25 and 26 June at the NYSE Euronext in London.  The event focused on the top 20 healthcare, lifescience and medtech companies in Europe.  The theme of the event was: Crossing the chasm from startup to a sustainable high growth business. This event was a showcase of the best European entrepreneurs and provided significant visibility and media coverage for the selected companies. 

Read more

Abstract on first published alfapump® case in a patient with cancer presented at ASCO

31 May 2013

The case study, reported by the Ovarian Cancer Action Research Centre at Imperial College NHS Trust, London, is presented at this year's American Society of Clinical Oncology. Read the abstract here.

Read more

Interview with Dr. Andrea De Gottardi

2 May 2013

Inselmagazin, the in-house magazine for the University Hospital Bern interviews Dr. Andrea De Gottardi on his experiences with the alfapump system. Read the article here.

Read more

alfapump® at EASL

22 April 2013

Sequana Medical will be presenting the alfapump system at this year’s International Liver Congress in Amsterdam, taking place from the 24th to 28th of April.  Visit us in the exhibition hall at stand 28.

Read more

University of Modena and Reggio Emilia implant Italy’s first patients with Sequana Medical’s alfapump® system

13 March 2013

Swiss company’s innovative technology for the management of refractory ascites significantly reduces the need for large-volume paracentesis.

Read more

Dr. Noel L. Johnson and Professor Hani Gabra present the alfapump® system at the Royal Society of Medicine Innovations Summit

16 February 2013

Dr Noel L. Johnson, President and CEO of  Sequana Medical, and Professor Hani Gabra, honorary consultant in medical oncology, Hammersmith Hospital, and director, Overian Cancer Action Research Centre, were invited to present the alfapump system and its role in the management of malignant ascites at Royal College of Medicine's annual Medical Innovations summit. 

Watch the podcast here.

Read more

MDR reports on the alfapump® system

14 February 2013

German TV channel MDR reported on the alfapump experience at the University Hospital of Leipzig. To watch the report (in German), visit our video section on

Read more

'The Times' reports on first alfapump® implant in patient with malignant ascites due to ovarian cancer

18 January 2013

UK national newspaper The Times describes the alfapump as 'game-changing technology' in this report on the first ever alfapump implant in a patient with ovarian cancer.  Read the article.

Read more


8 January 2013

Listen to a report broadcast on Deutschlandradio about the alfapump experience at Hannover Medical School (in German).

Read more